Goldman Sachs
ELAN icon

Goldman Sachs’s Elanco Animal Health ELAN Stock Holding History

Goldman Sachs’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100,000
Closed -$2.26M – 6619
2025
Q4 		$2.26M Buy
+100,000
New +$2.18M ﹤0.01% 4470
2020
Q3 		– Sell
-117,900
Closed -$2.53M – 5362
2020
Q2 		$2.53M Buy
117,900
+67,900
+136% +$1.5M ﹤0.01% 3288
2020
Q1 		$1.12M Buy
+50,000
New +$1.37M ﹤0.01% 3673

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Goldman Sachs's ELAN Position: Q2 2026 in Review

Goldman Sachs reduced its Elanco Animal Health (ELAN) stake by 1.5% in Q2 2026, selling an estimated $507K and leaving 1,412,190 shares worth $34.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2126.

Goldman Sachs first reported a position in ELAN in Q3 2018 and has held it in 32 quarters since. The position peaked at $345M in Q2 2021. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Goldman Sachs held 1,412,190 shares of Elanco Animal Health worth $34.8M as of Q2 2026.
  • Goldman Sachs sold 21,945 Elanco Animal Health shares in Q2 2026, an estimated $507K.
  • Elanco Animal Health made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2126 holding.
  • Goldman Sachs first reported a position in Elanco Animal Health in Q3 2018 and has held it in 32 quarters since.
  • Goldman Sachs's Elanco Animal Health position peaked at $345M in Q2 2021.
  • 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.